Some did. But I have a lot more.
I did my due diligence (something you wouldn't dream of) of researching your claim. I found zero sites that added context. Dozens of sites that simply did what you did, many unsourced. And zero legitimate medical and/or statistical site that would corroborate your claim.
A thinking person must call bullshit on your bullshit. But, I will wait until you tell me or find anything that says what those numbers mean, If in fact they are real.
I won't hold my breath
The information on this website relates to suspected side effects , i.e. medical events that have been observed following the use of a medicine, but which are not necessarily related to or caused by the medicine.
bullet Information on suspected side effects should not be interpreted as meaning that the medicine or the active substance causes the observed effect or is unsafe to use. Only a detailed evaluation and scientific assessment of all available data allows for robust conclusions to be drawn on the benefits and risks of a medicine.
The European Medicines Agency publishes these data so that its stakeholders, including the general public, can access information that European regulatory authorities use to review the safety of a medicine or active substance. Transparency is a key guiding principle of the Agency.
I did my due diligence (something you wouldn't dream of) of researching your claim. I found zero sites that added context. Dozens of sites that simply did what you did, many unsourced. And zero legitimate medical and/or statistical site that would corroborate your claim.
A thinking person must call bullshit on your bullshit. But, I will wait until you tell me or find anything that says what those numbers mean, If in fact they are real.
I won't hold my breath
The information on this website relates to suspected side effects , i.e. medical events that have been observed following the use of a medicine, but which are not necessarily related to or caused by the medicine.
bullet Information on suspected side effects should not be interpreted as meaning that the medicine or the active substance causes the observed effect or is unsafe to use. Only a detailed evaluation and scientific assessment of all available data allows for robust conclusions to be drawn on the benefits and risks of a medicine.
The European Medicines Agency publishes these data so that its stakeholders, including the general public, can access information that European regulatory authorities use to review the safety of a medicine or active substance. Transparency is a key guiding principle of the Agency.